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ABSTRACT: Venom of the South American rattlesnake, Crotalus durissus terrificus 
(Cdt), presents myotoxic and neurotoxic outcomes, but reports on its effects on the 
liver are scarce. This study examined the hepatotoxicity resulting from Cdt venom 
administration (100, 200 and 300 μg/kg) in male Wistar rats. Animals were studies at 
3, 6, 9 and 12 hours after venom injection. The hepatotoxicity was assessed through 
serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), 
alkaline phosphatase (AP), gamma glutamyl transferase (GGT), bilirrubin and also by 
histopathological evaluation. All the different concentrations of Cdt venom resulted in 
increased levels of hepatic enzymes, when compared with the control group, except 
for the 100 μg/kg dose, which presented normal levels at 9 and 12 hours after venom 
administration. Bilirrubin levels remained unchanged by Cdt venom. Histological 
analysis revealed endothelial damage, inflammatory cell infiltration, as well as 
sinusoidal and portal congestion. Based on these observations, we may conclude 
that Cdt venom causes dose- and time-dependent hepatic damage in rats, 
characterized by elevated hepatic enzyme levels and histological alterations. 
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INTRODUCTION 
The South American rattlesnake, Crotalus durissus terrificus, presents a wide 
distribution throughout southeastern Brazil (1). Envenomations by this species 
account for 6 to 8% of all registered bites by venomous snakes in the country, with 
an approximate mortality rate of 1.8%, the highest among venomous species (2). C. 
d. terrificus venom contains a variety of toxins, including convulxin (3), crotamine (4), 
crotoxin – its main neurotoxin, which accounts for nearly 50% of the venom dry 
weight (5) – and gyroxin (6-8), as well as several enzymes common to other snake 
venoms (9, 10). 
Experimental and clinical envenomations by C. d. terrificus venom result mainly in 
myotoxicity and neurotoxicity, while the most effective treatment is administration of 
anticrotalic antivenom (11). Whereas some consequences of C. d. terrificus venom 
have been extensively studied – such as myonecrosis (12-17), coagulation 
disturbances (7, 8, 18-20), neuromuscular effects (21, 22), renal involvements (14, 
23) and homeostatic problems (20) – considerably less attention has been paid to its 
effects on the liver. 
In humans, envenomation by C. d. terrificus causes hepatic lesions involving 
necrosis, effects attributed to release of pro-inflammatory cytokines (24-27). Also, 
hepatic steatosis and increased serum aspartate aminotransferase (AST) levels were 
reported by Azevedo Marques et al. (14) in patients bitten by C. d. terrificus and 
extensive hepatic necrosis by Barraviera et al. (24). In addition, Barraviera et al. (25) 
showed increased serum levels of AST (86%) and ALT (66%), by hepatocyte 
electron microscopy that showed mitochondrial damage, suggesting that liver injury 
may occur partly in the cytoplasm and partly in the mitochondria. Bancher, Rosa and 
Furlanetto (28) proved that, in mice, the venom could be detected in hepatic tissue. 
The liver is a multifunctional organ, responsible for vital functions and for 
maintenance of energy balance in the organism. The release of intracellular enzymes 
into circulation is frequently used as an indicator of hepatocyte damage (29), 
although the release of some enzymes like AST and ALT – also present in tissues 
other than liver – needs to be evaluated by other injury markers to confirm any 
hepatic damage. Therefore, in the present study, we examined the liver damage 
induced by C. d. terrificus venom in rats through enzymatic markers of liver function 
and also by histological analysis. 
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MATERIALS AND METHODS 
Venoms and Reagents 
The kits for the quantification of serum enzymes and bilirubin were from Labtest 
Diagnóstico (Brazil). The reagents for histology were purchased from Synth (Brazil). 
C. d. terrificus venom was obtained by manual milking of snakes (both sexes) 
collected in the region of São José dos Campos and maintained in the snake house 
of the Nature Study Center, Vale do Paraíba University. The venom was lyophilized 
and stored at 4°C. Stock solutions of venom were prepared in sterile 0.9% NaCl 
immediately before use. 
 
Animals 
Male Wistar rats (180-220 g) obtained from Bem-te-vi Farm (Indaiatuba, SP, Brazil) 
were maintained in a 12-hour-light/dark cycle at 23 ±2°C with free access to food and 
water. Animal procedures described herein were approved by the institutional Animal 
Research Ethics Committee of UNIVAP (protocol number L035/2004/CEP) and 




To study the hepatotoxicity of C. d. terrificus venom, rats (283 per group) received an 
intramuscular injection of sterile saline solution only or venom (100, 200 or 300 
µg/kg) with saline solution in a final volume of 100 µL. The rats were subsequently 
killed with an overdose of ether at 3, 6, 9 or 12 hours after saline or venom injection 
(7 rats/time interval in each group) and blood was collected from the inferior vena 
cava. Samples of hepatic tissue were also obtained for histological analysis. 
 
Serum Enzyme Activities and Bilirubin Levels 
Serum alanine aminotransferase (ALT), alkaline phosphatase (AP), aspartate 
aminotransferase (AST) and γ-glutamyl transferase (GGT) activities were determined 
spectrophotometrically, as described by Reitman and Frankel (30), Szasz (31) and 
Roy (32). Bilirubin tests were made by a chosen diazo-coupling reagent and by a 
spectrophotometric method, according to Winsten and Cehelyk (33).  
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Histomorphometrical Analysis 
Liver fragments from rats killed at different times after venom administration were 
fixed in 10% formaldehyde overnight and then dehydrated in an increasing alcohol 
series, clarified with xylol and embedded in paraffin. Sections of 5-µm-thick were cut 
by a microtome (American Optical Co., USA) and stained with hematoxylin and 
eosin, for subsequent examination and documentation by an Olympus CX-41® 
microscope (Olympus Optical, USA) fitted to an Olympus PM10SP Automatic 
Photomicrographic® system (Olympus America Medical, USA). Twenty fields were 
analyzed for each slide. Using a 100-point grid with a known area (10,000 μm2 at 
1,000x magnification) attached to the microscope lens the number of points 
contacting the Kupffer cells and leukocytes were counted within a total area (10,000 
μm2). The density of congested blood vessels, endothelial area and degenerated 
hepatocytes were counted and the values adjusted to the total tissue area (10,000 
μm2). The density of Kupfer and mononuclear cells, as well as the density of 
congested blood vessels, endothelial area and degenerated hepatocytes were 
expressed as number of cells/mm2 of tissue. For a qualitative histological evaluation, 
the following criteria were used to determine the histologic score (scale 0-10): 0 = 
negative; 0.5 to 2.0 = mild; 2.5 to 5.5 = moderate; 6.0 to 8.0 = severe; 8.5 to 10.0 = 
very severe (34). 
 
Statistical Analysis 
The results were expressed as mean ± SEM and statistical comparisons were 
performed by Student’s t-test or one-way of variance (Anova) followed by the Tukey-
Kramer test. The p value was considered significant (p < 0.05); very significant (p < 
0.01) and extremely significant (p < 0.001).  
 
RESULTS 
Serum Liver Enzyme Activities and Bilirubin Levels 
Figure 1A shows the changes in AST levels at various time intervals following the 
injection of different doses of C. d. terrificus venom. The administration of 100 μg/kg 
of the venom resulted in increased AST activity at 3 hours when compared to the 
control group (p < 0.05), but no differences after 6, 9 and 12 hours (p > 0.05). 
Regarding the 200- and 300-μg/kg venom doses, we observed an increased AST 
activity at all times (3, 6, 9 and 12 hours) relative to the control group (p < 0.05).  
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Figure 1B reveals the changes in ALT levels at diverse intervals after administration 
of different concentrations of C. d. terrificus venom. Concerning the 100-μg/kg dose, 
no changes in ALT activity was found, when compared with the control group at 3, 6, 
9 and 12 hours (p > 0.05). The 200-μg/kg concentration of C. d. terrificus venom 
augmented ALT activity only at 9 and 12 hours relative to the control group (p < 
0.05). At the dose of 300 μg/kg of C. d. terrificus venom, the ALT activity was greater 
than in the control group at 3, 6, 9 and 12 hours (p < 0.05). 
AP activity increased progressively after the administration of all venom doses, 
although a significant change was seen only with the highest dose (300 μg/kg) at 12 
hours post-venom (Figure 1C). GGT levels showed a peak increase 6 hours after 
administration of the lowest dose, with a return to the pre-venom levels at 12 hours 
post-venom. A moderate and persistent rise in GGT activity was registered with the 
intermediate dose (200 μg/kg), while the highest one produced a progressive 
increase during the 12 hours after venom administration (Figure 1D). Figure 1E 
shows that total bilirubin levels were not changed by any venom dose or time 
interval. 
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Figure 1. Serum enzyme activities and bilirubin levels. Enzymes were collected from 
rat sera 3, 6, 9 and 12 hours after administration of 100, 200 and 300 μg/kg of Cdt 
venom. (A) Alanine aminotransferase (ALT); (B) aspartate aminotransferase (AST); 
(C) alkaline phosphatase (AP); (D) gamma glutamyl transferase (GGT) and (E) total 
bilirubin concentration. Data expressed as mean values ± S.E.M for 7 rats per group; 
*p < 0.05 when compared to the control group and analyzed by one-way Anova, 
followed by Tukey-Kramer multiple comparisons test. 
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Histological Analysis 
Sections of hepatic tissue from saline-treated (control) rats showed normal 
hepatocytes with strongly stained nuclei and protein-rich cytoplasm. Transversal 
sections showed intact sinusoids, portal spaces and a lobular central vein (Figure 
2A). In contrast, rats injected with 100 µg/kg showed damage caused by an 
inflammatory infiltrate 3 and 6 hours after venom injection (Figure 2B). At 9 and 12 
hours post-venom, the appearance of the tissue had returned to normal (Figure 2C). 
However, the morphometric analysis did not show statistical differences between the 
control group and 100 µg/kg group. At the venom dose of 200 µg/kg, copious cellular 
infiltrate and the extent of damage augmented with time (Figure 2D). The 
morphometric analysis showed that at 200 µg/kg at 12 hours, the densities of Kupfer 
cells, endothelium and degenerated hepatocytes were increased when compared 
with the control group. The density of congested blood vessels at 9 hours was higher 
than in the control group. At the highest venom dose (300 µg/kg), the hepatocytes 
showed marked disorganization, with swelling, necrosis and a progressive increase 
in damage up to 12 hours after venom administration (Figure 2E). Moreover, the 
histomorphometric findings demonstrate in Table 1 that at 9 hours, the density of 
Kupfer cells, congested blood vessels, endothelium densities and degenerated 
hepatocyte were greater than in those of control group. At 12 hours, all parameters 
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Figure 2. Histological analysis. (A) Photomicrograph of hepatic tissue from the 
control group (HE, 400x). See hepatic artery ( ), biliary duct ( ), portal 
vein ( ). (B) Photomicrograph of hepatic tissue 6 hours after venom injection 
(100 μg/kg) (HE, 400x). Observe vascular congestion ( ), inflammatory infiltrate 
( ) and increased density of Kupffer cells ( ). (C) Photomicrograph of 
hepatic tissue 12 hours after venom injection (100 μg/kg) (HE, 400x). A few 
inflammatory cells and plate hepatocytes. (D) Photomicrograph of hepatic tissue 6 
hours after venom injection (200 μg/kg) (HE, 400x). Dense inflammatory infiltrate and 
portal vein congestion. (E) Photomicrograph of hepatic tissue 12 hours after venom 
injection (300 μg/kg) (HE, 400x). Damaged hepatic vascular system showing high 
inflammatory infiltrate; hepatocyte degeneration. 
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6h 4.21±1.18*** 5.58±1.81*** 6.53±1.37*** 3.47±1.60*** 3.95±1.05*** 







6.74±1.76*** 6.10±1.66*** 9.58±0.37*** 7.74±1.54*** 6.00±0.78*** 
 
Morphometric analysis of liver histological aspects found in the control group and Cdt venom group 
(100 µg/kg; 200 µg/kg and 300 µg/kg) 3, 6, 9 and 12 hours after administration (7 rats per group). Data 
expressed as intensity score scale from 0 to 10: 0 = negative; 0.5 to 2.0 = mild; 2.5 to 5.5 = moderate; 
6.0 to 8.0 = severe; 8.5 to 10.0 = very severe. *p < 0.05; **p < 0.01 and ***p < 0.001 vs. shocked rats  
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DISCUSSION 
The present study showed that the Crotalus durissus terrificus venom augments 
activity of hepatic enzymes and also produces histological alterations, suggesting 
hepatotoxicity. 
The liver maintains the organism’s energy supply for many functions, such as 
producing substances that break down fats, converting glucose to glycogen, 
producing urea, synthesizing certain amino acids, filtering harmful substances and 
maintaining a proper blood glucose level. There are some intracellular enzymes that 
are released into the circulation and are frequently used as an indicator of damage to 
hepatocytes. The principal marker enzymes include alanine (ALT) and aspartic (AST) 
aminotransferases, which catalyze the transfer of α-amino groups from alanine and 
aspartate to the α-keto group of ketoglutaric acid to produce pyruvic acid and 
oxaloacetic acid, respectively (29). ALT is a more specific marker of hepatocellular 
injury, and occurs in the liver, kidneys, heart, skeletal muscle and pancreas, whereas 
AST has a wider distribution, occurring in organs such as heart, liver, skeletal 
muscles, kidneys and pancreas. In the liver, AST occurs predominantly (80%) in 
mitochondria and 20% in the cytoplasm, whereas ALT is confined to the cytoplasm 
(29, 35). Other enzymes such as alkaline phosphatase (AP) and γ-glutamyl 
transferase (GGT) may also be used as markers of hepatic dysfunction, although 
they are found in the liver, bone, the kidneys and its enhancement is related to 
production elevation or excretion deficit, such as obstructive jaundice and 
cholestasis. GGT is present in the liver, kidney and pancreas. Bilirubin is a pigment 
derived from the catabolism of the heme radical in hemoproteins such as 
hemoglobin, while increased serum levels of this pigment can indicate cholestatic 
processes and hepatocellular damage. 
The measurement of serum enzyme activities in clinical studies, after C. d. terrificus 
venom administration, showed increased levels of creatine kinase (14, 16, 18, 36), 
creatine phosphokinase (14), lactate dehydrogenase (14, 16, 36), aspartate 
aminotransferase (36) and glutamic-oxaloacetic transaminase (14), primarily as 
consequences of venom myotoxic action (11), as well as injury markers of cardiac 
muscle disturbance similar to those of skeletal muscles (7, 36). Serum levels of 
alkaline phosphatase and alanine aminotransferase were also elevated in dogs 
treated with C. d. terrificus venom (1 mg/kg, IM) (20). Approximately half of the 
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patients bitten by C. d. terrificus show coagulation disorders primarily mediated by 
thrombin-like enzymes present in this venom (8, 18).  
A study in dogs revealed that C. d. terrificus venom causes marked alterations in 
hematological, hemostatic and biochemical parameters that may also be seen, 
through histological examination, as intravascular coagulation in cardiac and hepatic 
tissues (20). These authors also showed a progressive increase of serum levels of 
myoglobin, creatine kinase and aspartate aminotransferase demonstrated that 
animals developed rhabdomyolysis. On the other hand, AP did not increase 
expressly. Probably, this is related to cholestatic diseases, which is plausible 
because, like AP, bilirubin concentration did not increase over time and, as outlined 
in the preceding sections, is also related to cholestatic process (35-37). 
As proven by the current study, the administration of C. d. terrificus venom to rats 
resulted in increased circulating levels of enzymes (ALT, AST and GGT) that are 
frequently employed as indicators of hepatic damage and cholestasis. The increased 
AST levels observed in the present work are similar to elevated serum activity of the 
same enzyme after human envenomations (24, 11). Changes in serum levels of 
other enzymes, including creatine kinase (CK) and lactate dehydrogenase (LDH), 
have also been observed in human envenomations (11).  However, there are 
differences in kinetic profiles of these alterations. For example, CK and LDH levels 
present their peaks respectively before and after other enzymes. The hepatic 
damage caused by the smallest venom dose (100 µg/kg), assessed by enzyme 
release and histological analysis (Table 1), appeared to be minimal and reversible. 
Higher venom doses (200 and 300 µg/kg) resulted in greater damage that was not 
reversible within the time scale of the present experiments. In part, this hepatotoxicity 
is probably mediated by PLA2 component of crotoxin, which presents the ability to 
interfere in hepatic mitochondrial respiration (38). The presence of inflammatory 
infiltrates associated with severe damage indicates that C. d. terrificus venom and its 
components are capable of affecting macrophage function and stimulating cytokine 
production (39, 40). These findings agree with the demonstrations of acute phase 
inflammatory reactions in humans bitten by C. d. terrificus (26). 
The venom components responsible for the hepatotoxicity are still undetermined, but 
they probably involve PLA2 action on cell membrane lipids and mitochondrial 
respiration (38), as well as various cell types such as lymphocytes (41, 42), 
macrophages (39, 40, 43, 44), mast cells (45), and platelets (3, 46-49). In support of 
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this conclusion, crotoxin – which presents all PLA2 activity of C. d. terrificus venom – 
has been implicated in numerous effects, including neurotoxicity (22), myotoxicity 
(12, 50, 51), renal toxicity (52), edema (45, 51), inhibition of macrophage activity (40, 
44), immunosuppression (42), stimulation of the hypothalamo-pituitary-adrenal axis 
(including increased plasma glucose, ACTH, corticosterone and TNF-α levels) and of 
corticotropin-releasing hormone (CRH) and of arginine vasopressin pathways (53), 
and cytostatic (54) and cytotoxic (55) effects in cancer cell lines. 
Coagulation disturbances (19, 20) leading to fibrin deposition and ischemia, mainly 
through the action of the thrombin-like enzyme (gyroxin) of this venom (8, 9, 19) 
could also contribute to the hepatic damage registered in the present study. In 
addition, considering the inter- and intrasubspecific variation in the composition and 
biological activities of this venom (51, 56-61), there may be differences in hepatic 
effects produced by venoms obtained from C. d. terrificus specimens from other 
regions, and among other subspecies like C. d. cascavella, C. d. collilineatus, C. d. 
durissus and C. d. ruruima. Finally, diverse susceptibilities of animal strains and 
species (18) may also contribute to variations in hepatic effects of this venom. 
The present study provides evidence that Crotalus durissus terrificus venom induces 
hepatotoxicity in rats, by increasing blood liver enzymes, probably derived from liver, 
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